One of the key factors fueling the growth of the global hormone replacement therapy market is increasing acquisitions. Pfizer Inc., a pharmaceutical firm headquartered in the United States, combined with OPKO Health Inc., a business based in the U.S., in 2014 to create a long-acting growth hormone (hGH-CTP) and novel therapies for growth hormone deficient individuals. hGH-CTP is more convenient since patients just require one injection each week instead of daily dosages. In the U.S. and Europe, hGH-CTP has been designated as an orphan medication for children and adults with growth hormone deficiencies.
The expansion of the global hormone replacement therapy market is projected to be aided by a strong pipeline. In 2017, Novo Nordisk A/S, a Danish firm, completed phase 3 clinical studies for Somapacitan. This medication is used to treat adult testosterone deficiency.
FREE | Request Sample is Available @https://www.coherentmarketinsights.com/insight/request-sample/2079
*The Sample only consist ofTable of Content (ToC).Research Frameworkof the actual report.Research Methodologyadopted for it.
Major Company Profiles Covered in This Report:Novartis AG, Abbott Laboratories, Mylan N.V., Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company.
The market for hormone replacement treatment is projected to expand due to the rising prevalence of various chronic diseases.
The market for hormone replacement treatment is projected to expand due to the rising prevalence of hypogonadism in adult males throughout the world. Hypogonadism affects 2.1 percent to 12.8 percent of middle-aged men, according to the European Association of Urologys 2016 study. In Europe, the prevalence of low testosterone and hypogonadism symptoms in males aged 40 to 79 ranges from 2.1 percent to 5.7 percent.
The expansion of the global hormone replacement therapy market is projected to be aided by easier access and government assistance for research and development efforts. NGOs such as the National Gaucher Society provide financial assistance to patients who require expensive insulin replacement treatment.
Request Free research report Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/2079
Companies are concentrating their efforts on creating generic versions of numerous medications for the treatment of diseases that are more common in women, such as hypothyroidism. On July 24, 2017, Teva Pharmaceutical Industries Ltd. introduced a generic version of Vagifem, 10 mcg, in the United States. Estradiol vaginal inserts are a kind of oestrogen used to treat atrophic vaginitis caused by menopause.
Furthermore, Mylan N.V. received FDA clearance for its Abbreviated New Medication Application (ANDA) for Estradiol Vaginal Cream USP, 0.01 percent on December 29, 2017, and therefore marketed the drug in the U.S. This cream is the first generic alternative to Allergans Estrace Cream, which is used to treat vulvar and vaginal atrophy.
Mylan is one of the few firms that sells Estradiol in cream, gel, transdermal patch, and tablet form. This will benefit both healthcare personnel and patients, as well as ensuring the businesss long-term viability.
Major companies contributing in the global hormone replacement therapy market are Pfizer Inc., QuatRx Pharmaceuticals, Mylan N.V., Abbott Laboratories, Amgen, Inc., Novartis AG, Eli Lilly and Company, Bayer AG, Merck KgaA, Teva Pharmaceutical Industries Ltd., and Novo Nordisk A/S.
Inquire more about this report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/2079
Some Notable Offerings by Coherent Market Insights Report on Hormone Replacement Therapy market:
We will provide you an analysis of the extent to which this Hormone Replacement Therapy market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better.
We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others.
Also, this report will help you to identify any trends to forecast growth rates.
The analyzed report will forecast the general tendency for supply and demand.
Also, Research Report Examines:
Competitive companies and manufacturers in global market
By Product Type, Applications & Growth Factors
Industry Status and Outlook for Major Applications / End Users / Usage Area
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Read more from the original source:
[PDF] Hormone Replacement Therapy Market to Reflect Steady Growth and Future Scope UNLV The Rebel Yell - UNLV The Rebel Yell
- Testosterone replacement therapy: Yes or no - MD Anderson Cancer Center - January 6th, 2024
- 5 Best Testosterone Replacement Therapy Services 2023 - Men's Health - January 6th, 2024
- How Much Is Testosterone? The Cost of Replacement Therapy - Hone Health - January 6th, 2024
- Testosterone Replacement Therapy - Department of Urology - January 6th, 2024
- Testosterone Replacement Therapy for Low T - Ageless Men's Health - January 6th, 2024
- Understanding Hypogonadism, Testosterone Replacement Therapy, and Prostate Cancer Risk - Medriva - January 6th, 2024
- TRAVERSE Trial: Insights into Testosterone Replacement Therapy Safety - BNN Breaking - January 6th, 2024
- Testosterone replacement therapy may not increase risk of prostate cancer among men with hypogonadism - Medical Dialogues - January 6th, 2024
- Testosterone Replacement Therapy (TRT): Is It Right For You? - December 2nd, 2023
- Low Testosterone (Low T): Causes, Symptoms & Treatment - Cleveland Clinic - March 28th, 2023
- LowTCenter: Men's Health Clinic for Testosterone Replacement - March 28th, 2023
- Testosterone Replacement Therapy for Men | SynergenX - March 28th, 2023
- Male hypogonadism - Diagnosis and treatment - Mayo Clinic - February 6th, 2023
- Testosterone Replacement Therapy (TRT) Experts | Optimale - December 2nd, 2022
- Testosterone Replacement Therapy Clinic - EHormones MD - November 24th, 2022
- Options to Increase Your Testosterone - Healthline - November 16th, 2022
- Masculinizing hormone therapy - Wikipedia - October 29th, 2022
- Testosterone: What It Is and How It Affects Your Health - October 13th, 2022
- Testosterone What It Does And Doesn't Do - Harvard Health - October 13th, 2022
- Cork woman felt like she lost part of herself after going into menopause aged 27 - RSVP Live - October 13th, 2022
- The Global Testosterone Replacement Therapy Market is - October 4th, 2022
- Hypogonadism in Men | Endocrine Society - October 4th, 2022
- The One Thing This Doctor Says Is A Game Changer When It Comes To Hormones And Aging - TravelAwaits - October 4th, 2022
- Shirley Ballas on her difficult experience with menopause - Good Housekeeping - October 4th, 2022
- Foods That Boost Testosterone: 7 Options and How They Work - Healthgrades - October 4th, 2022
- Dr. Roach: Testosterone injections most likely led to severe stroke - Detroit News - October 4th, 2022
- What To Know About Perimenopause, And How To Manage Symptoms Once They Kick In - The Zoe Report - October 4th, 2022
- CORRECTION -- Marius Pharmaceuticals Receives FDA Approval of KYZATREX, an Oral Testosterone Replacement Therapy - GlobeNewswire - September 25th, 2022
- Testosterone replacement therapy - PubMed - September 16th, 2022
- Risks of testosterone replacement therapy in men - PMC - September 16th, 2022
- The Global Testosterone Replacement Therapy Market is expected to grow by $ 402.87 mn during 2022-2026, accelerating at a CAGR of 3.1% during the... - September 16th, 2022
- Testosterone injections most likely led to a very severe stroke - The Independent - September 16th, 2022
- Best DHEA Supplement (2022 Updated) - The Island Now - September 16th, 2022
- Testosterone Replacement Therapy in the Aged Male: Monitoring Patients | IJGM - Dove Medical Press - September 8th, 2022
- ROACH: Testosterone injections most likely led to a very severe stroke - New Castle News - September 8th, 2022
- Perform Your Best With Comprehensive Bloodwork - duPont REGISTRY News - September 8th, 2022
- What I Learned When I Stopped Testosterone Replacement Therapy |... - Cushing's Disease News - August 30th, 2022
- From White Plains Hospital: Feeling the Effects of Man-o-pause? - theLoop - August 30th, 2022
- SARMs Before And After Results Real SARM Results And Users Review In 2022 - Outlook India - August 30th, 2022
- Larry Wheels Stops Using Steroids: "I Am Going To Be On Testosterone Replacement Therapy" Fitness Volt - Fitness Volt - August 22nd, 2022
- Hormone Replacement Therapy for Men: What to Know - Healthline - August 14th, 2022
- Testosterone Replacement Therapy Market Trends, Analysis, Demand and Global Industry Research Report, Region, and Segment Forecasts 2028 - Digital... - August 14th, 2022
- Cycling and HRT: How will it affect me? - Cyclist - August 14th, 2022
- 6 LGBTQ2S+ musicians celebrate the artists who came before them - CBC.ca - August 14th, 2022
- 'I kept thinking I was having a heart attack but it was the perimenopause' - iNews - July 27th, 2022
- Obese women with high intake of vitamin C and B6 associated with lower breast cancer risk cohort study - NutraIngredients-Asia - July 27th, 2022
- Testosterone Replacement Therapy Market | Incredible Possibilities, Growth, Trend, Opportunities Detailed Analysis and Forecast to 2030 Travel... - July 19th, 2022
- Low on the Male Hormone? 5 Effective Ways to Boost It - Times Square Chronicles - July 19th, 2022
- Ostarine MK-2866 | Review, Alternatives,Side Effects and Results-Health News - Firstpost - July 19th, 2022
- Trans teens: We need to be heard, counted. In Michigan, the backlash is harsh - Bridge Michigan - July 19th, 2022
- Testosterone Therapy Improves Erectile Function and Libido in ... - July 11th, 2022
- Low Testosterone and What You Can Do About It - The Epoch Times - July 11th, 2022
- How Long Does It Take to Feel the Benefits of Testosterone Replacement ... - July 3rd, 2022
- TRT Testosterone Replacement Therapy Clinic - Peter Uncaged MD - July 3rd, 2022
- Men have it too - The Hans India - July 3rd, 2022
- New guidelines for menopause care say women should be offered personalised treatment including diet and HRT - iNews - July 3rd, 2022
- Head-To-Head Contrast: Biogen (NASDAQ:BIIB) and Clarus Therapeutics (NASDAQ:CRXT) - Defense World - July 3rd, 2022
- Im a GP heres the truth behind Davina McCalls claims about HRT and dementia... - The Sun - July 3rd, 2022
- How To Spot The Best Clinic For Your Hormone Replacement Therapy - My MMA News.com - June 22nd, 2022
- Testosterone May Aid Memory in Men With Uncontrolled Diabetes - Everyday Health - June 22nd, 2022
- Boyfriend has been secretly taking testosterone tablets and I worry he may go sterile... - The Sun - June 22nd, 2022
- Sex and aging: Overview, stats, and maintaining satisfaction - Medical News Today - June 22nd, 2022
- Once a Taboo Topic, Menopause Is (Finally) Having Its Wellness Moment - Vogue - June 4th, 2022
- Caitlyn Jenner can still hit golf ball nearly 300 yards after transitioning to female - Washington Times - June 4th, 2022
- Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) Receives $6.88 Consensus PT from Analysts - Defense World - June 4th, 2022
- Juvenile Macular Degeneration Treatment Market Set to Grow According to Forecasts 2020 2030 Industrial IT - Industrial IT - June 4th, 2022
- Testosterone Replacement Therapy Market 2022 to 2028 Global Industry Analysis, Growth, Trends and Forecast Queen Anne and Mangolia News - Queen Anne... - May 15th, 2022
- Being trans and starting HRT - The Advocate - May 15th, 2022
- DHEA Levels and Their Role in Fertility for Functional Medicine Patients - Digital Journal - May 15th, 2022
- LPCN: First Quarter 2022 Financial and Operational Results - Benzinga - May 15th, 2022
- LIPOCINE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - Marketscreener.com - May 15th, 2022
- No, red light therapy isnt a medically approved treatment for increasing testosterone - ABC10.com KXTV - May 2nd, 2022
- Tucker Carlsons answer to masculinitys supposed crisis? Testicle tanning - The Guardian - April 19th, 2022
- Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing - PR Newswire - April 19th, 2022
- Gilbert Gottfrieds myotonic dystrophy: 5 things to know about the rare genetic disorder - cleveland.com - April 19th, 2022
- Lia Thomas started a conversation about transgender rights. It's time we dive into it. - The Emory Wheel - April 19th, 2022
- Who are the teens at the center of the legal fight over Alabamas law banning transgender treatment? - AL.com - April 19th, 2022
- In Venice, a Young Boatman Steers a Course of His Own - The New York Times - April 19th, 2022
- Female athletes are as capable as male athletes | Opinion | kansan.com - The University Daily Kansan - April 19th, 2022
- FDA Approves Oral Testosterone Replacement Therapy for Hypogonadism - Pharmacy Times - April 6th, 2022